Slate Path Capital as of March 31, 2020
Portfolio Holdings for Slate Path Capital
Slate Path Capital holds 26 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Barrick Gold Corp (GOLD) | 14.3 | $186M | 10M | 18.32 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 12.6 | $164M | 376k | 436.31 | |
| Mylan Nv | 12.3 | $161M | 11M | 14.91 | |
| New York Times Company (NYT) | 10.2 | $133M | 4.3M | 30.71 | |
| Snap Inc cl a (SNAP) | 8.7 | $114M | 9.6M | 11.89 | |
| Alnylam Pharmaceuticals (ALNY) | 6.0 | $78M | 718k | 108.85 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 5.9 | $77M | 2.2M | 36.02 | |
| Mosaic (MOS) | 5.4 | $71M | 6.5M | 10.82 | |
| Bausch Health Companies (BHC) | 5.0 | $66M | 4.2M | 15.50 | |
| Pan American Silver Corp Can (PAAS) | 4.9 | $64M | 4.4M | 14.33 | |
| Kirby Corporation (KEX) | 4.3 | $56M | 1.3M | 43.47 | |
| Freeport-McMoRan Copper & Gold (FCX) | 3.9 | $51M | 7.5M | 6.75 | |
| Ironwood Pharmaceuticals (IRWD) | 1.0 | $14M | 1.3M | 10.09 | |
| Endo International (ENDPQ) | 1.0 | $13M | 3.4M | 3.70 | |
| Cue Biopharma (CUE) | 0.9 | $12M | 871k | 14.19 | |
| iShares MSCI Emerging Markets Indx (EEM) | 0.9 | $11M | 333k | 34.13 | |
| Uniqure Nv (QURE) | 0.5 | $6.6M | 140k | 47.45 | |
| Zillow Group Inc Cl A (ZG) | 0.5 | $6.3M | 185k | 33.97 | |
| Lexinfintech Hldgs (LX) | 0.3 | $3.9M | 440k | 8.87 | |
| Wayfair (W) | 0.3 | $3.7M | 70k | 53.44 | |
| Blue Apron Hldgs Inc Cl A | 0.3 | $3.6M | 297k | 12.05 | |
| Atara Biotherapeutics (ATRA) | 0.3 | $3.6M | 420k | 8.51 | |
| Cyclerion Therapeutics | 0.2 | $3.2M | 1.2M | 2.65 | |
| Intelsat Sa | 0.1 | $1.7M | 1.1M | 1.53 | |
| Transocean (RIG) | 0.0 | $545k | 470k | 1.16 | |
| Arch Coal Inc cl a | 0.0 | $520k | 18k | 28.89 |
